VBI Vaccines Closes $23.6 Million Financing from Perceptive Advisors

Corporate Breaking News

Home : VBI Vaccines Closes $23.6 Million Financing from Perceptive Advisors

Dec 07 2016	VBI Vaccines Closes $23.6 Million Financing from Perceptive Advisors
CAMBRIDGE, MASSACHUSETTS--(Marketwired - Dec. 6, 2016) - VBI Vaccines Inc. (NASDAQ:VBIV) (TSX:VBV) ("VBI"), a clinical-stage biopharmaceutical company developing infectious disease and immuno-oncology vaccines, today announced that it has raised $23.6 million in concurrent equity and debt financing transactions with Perceptive Advisors.


Source:http://www.marketwired.com/mw/release.do?id=2181001&sourceType=3

Related News
» Arizona Mining Announces Closing of $36 Million Bought Deal Offering of Common Shares » Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials